See every side of every news story
Published loading...Updated

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

  • More than 600 people infected with Mpox fled treatment centers in the Democratic Republic of Congo due to fighting, according to the Africa Centers for Disease Control.
  • Although over 150 of those who escaped returned, many remain unaccounted for due to ongoing conflict in the region.
  • The M23 rebel group has hindered efforts to contain Mpox, affecting hospitals and medical supplies, reported Dr. Cikuru.
  • Authorities have started negotiations for a humanitarian corridor to allow aid access amid the conflict, as per Africa CDC's Mpox Incident Manager Dr. Ngashi Ngongo.
Insights by Ground AI
Does this summary seem wrong?

24 Articles

All
Left
4
Center
6
Right
1
castanet.netcastanet.net
+7 Reposted by 7 other sources
Center

Congo faces setback in mpox response after Rwanda-backed rebels advance in the east

Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a setback in detecting the disease and offering treatment following the advance of Rwanda-backed rebels in the region.

·Kelowna, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 55% of the sources are Center
55% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

barlamantoday.com broke the news in on Monday, March 10, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.